Between 1990 and 2019, age-standardized DALY rates for liver cancer showed a decreasing trend in East Asia and high-income Asia–Pacific regions, while they increased in Central Asia [ 5 ].
← all excerpts
The spatio-temporal trends and determinants of liver cancer attributable to specific etiologies: a systematic analysis from the Global Burden of Disease Study 2021.
1
—
—